Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis()

PURPOSE: We aimed to investigate the role of apolipoprotein A-I (ApoA-I) as a predictor of prognosis and treatment efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without bevacizumab. METHODS: We conducted a retrospective stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Qi, Huang, Yuanyuan, Chen, Qi, Qiu, Huijuan, Hu, Qiaozhen, Rong, Yuming, Li, Tingwei, Xia, Liangping, Zhang, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2017
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334545/
https://www.ncbi.nlm.nih.gov/pubmed/28292509
http://dx.doi.org/10.1016/j.tranon.2017.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334545/
https://www.ncbi.nlm.nih.gov/pubmed/28292509
http://dx.doi.org/10.1016/j.tranon.2017.01.006

Ejemplares similares